Plasma gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT) are validated surrogate markers for NAFLD and liver fat content [9, 10] as well as markers for metabolic syndrome and predictors for death [11]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.